Skip to Content
Course

Translational Regenerative Medicine

CLRE-237

This course is focused on the practical application of the principles of translating stem-cell-based therapies that focuses on the discovery, non-clinical development and Phase 1 clinical trials required to translate these interventions from the bench to the bedside. This course will highlight the unique aspects of stem-cell- based therapy discovery and development compared to drug discovery and development. Lectures given by a multidisciplinary team of academic subject matter experts will teach concepts that are linked to application of translational science principles to the discovery and development stem-cell-based therapeutics.

Learning Objectives
By the end of this course, the student should be able to:

Understand the bench to bedside concept
Understand the process of development of new stem-cell- based therapies
Understand the preclinical work needed to support first-in-human studies
Understand the discovery process in cell and gene therapy.
Describe the processes to deliver first-in-humans studies.
Understand basics for phase 1 first-in-human studies
Understand the regulatory landscape for cell and gene therapy.
Design a target product profile (TPP) for a cell or gene therapy product
Understand the human subject ethical issues

Course Information

2.00 units
TBD
Notes: Closed MAS course! Contact rep at 534-9159

Course sessions

Please contact the Office of Adv Prof Education & Development department at or for information about this course and upcoming sections.